FOXO3a and β-catenin co-localization: double trouble in colon cancer?
Yibing
Y
Yan
Mark R
MR
Lackner
D015179:Colorectal Neoplasms / Q000737:chemistry* / Q000188:drug therapy / Q000473:pathology; D051858:Forkhead Transcription Factors / Q000032:analysis* / Q000502:physiology; D006801:Humans; D009362:Neoplasm Metastasis; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D000081082:Phosphoinositide-3 Kinase Inhibitors; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000502:physiology; D051057:Proto-Oncogene Proteins c-akt / Q000037:antagonists & inhibitors / Q000502:physiology; D015398:Signal Transduction; D051176:beta Catenin / Q000032:analysis* / Q000502:physiology
D051858:Forkhead Transcription Factors; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D048493:Proto-Oncogene Proteins B-raf; D051057:Proto-Oncogene Proteins c-akt; D051176:beta Catenin; C495270:CTNNB1 protein, human; C418974:FOXP3 protein, human; C482119:BRAF protein, human